open access
Blood pressure control in tertiary-care hypertensive patients during COVID-19 pandemic
- Department of Hypertension and Diabetology, Medical University of Gdańsk, Gdańsk, Poland
- Department of Epidemiology, Prevention of Cardiovascular Diseases and Health Promotion, National Institute of Cardiology, Warsaw, Poland
- Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland
open access
Abstract
Background: Cardiovascular risk factors distribution during the pandemic suggests worsening of the cardiovascular risk profile of hypertensive patients. At the same time, data on quality of hypertension control during the COVID-19 pandemic are scarce, in Poland. The aim of the study was to analyse the quality of blood pressure (BP) control in a group of patients who required regular control in tertiary care.
Material and methods: The study included patients regularly monitored in Gdańsk Hypertension Centre for at least 4 years with at least 2 visits a year prior the analysis. The size of the group was calculated based on the original data of first 50 consecutive records of patients (power of 90%). Records were retrospectively analysed with respect to office blood pressure (oBP) control. Additionally, within-visit BP variability was calculated (difference of maximum and minimum BP from 3 measurements); body weight, age, sex, duration of hypertension, number of visits per year, seasonal BP variability, use of telemedical services, comorbidities and BP-lowering treatment were recorded.
Results: The study enrolled 220 patients. The values of systolic BP (sBP) before and after the break in the whole group were 135.8 ± 17.1 mm Hg vs. 137.9 ±19.5 mm Hg; P=0.08, and a diastolic BP (dBP) of 80.3 ±11.4 mm Hg vs. 82.6 ±12.2 mm Hg; p = 0.001. After adjusting for seasonal variation of BP, the respective differences were: sBP: 134.8 ± 16.5 vs. 138.0 ± 19.4; p = 0.03, and dBP: 79.4 ±10.9 vs. 82.2 ± 11.9; p = 0.004. Before 2020, 61.4% of patients were controlled (BP < 140/90 mm Hg), whereas after the pandemic-driven break in regular visits the control rate decreased to 55.5% (p = 0.21).
Conclusions: BP increased significantly and the rate of BP control decreased during the COVID-19 pandemic in a group of patients requiring tertiary care for hypertension.
Abstract
Background: Cardiovascular risk factors distribution during the pandemic suggests worsening of the cardiovascular risk profile of hypertensive patients. At the same time, data on quality of hypertension control during the COVID-19 pandemic are scarce, in Poland. The aim of the study was to analyse the quality of blood pressure (BP) control in a group of patients who required regular control in tertiary care.
Material and methods: The study included patients regularly monitored in Gdańsk Hypertension Centre for at least 4 years with at least 2 visits a year prior the analysis. The size of the group was calculated based on the original data of first 50 consecutive records of patients (power of 90%). Records were retrospectively analysed with respect to office blood pressure (oBP) control. Additionally, within-visit BP variability was calculated (difference of maximum and minimum BP from 3 measurements); body weight, age, sex, duration of hypertension, number of visits per year, seasonal BP variability, use of telemedical services, comorbidities and BP-lowering treatment were recorded.
Results: The study enrolled 220 patients. The values of systolic BP (sBP) before and after the break in the whole group were 135.8 ± 17.1 mm Hg vs. 137.9 ±19.5 mm Hg; P=0.08, and a diastolic BP (dBP) of 80.3 ±11.4 mm Hg vs. 82.6 ±12.2 mm Hg; p = 0.001. After adjusting for seasonal variation of BP, the respective differences were: sBP: 134.8 ± 16.5 vs. 138.0 ± 19.4; p = 0.03, and dBP: 79.4 ±10.9 vs. 82.2 ± 11.9; p = 0.004. Before 2020, 61.4% of patients were controlled (BP < 140/90 mm Hg), whereas after the pandemic-driven break in regular visits the control rate decreased to 55.5% (p = 0.21).
Conclusions: BP increased significantly and the rate of BP control decreased during the COVID-19 pandemic in a group of patients requiring tertiary care for hypertension.
Keywords
office blood pressure; COVID-19 pandemic; telemedicine
Title
Blood pressure control in tertiary-care hypertensive patients during COVID-19 pandemic
Journal
Issue
Article type
Original paper
Pages
145-151
Published online
2023-09-27
Page views
357
Article views/downloads
312
DOI
Bibliographic record
Arterial Hypertension 2023;27(3):145-151.
Keywords
office blood pressure
COVID-19 pandemic
telemedicine
Authors
Jacek Wolf
Anna Nieckarz
Anna Panfil
Aleksandra Białas
Julia Sternicka
Łukasz Jędrzejewski
Michał Hoffmann
Anna Szyndler
Aleksander Prejbisz
Michel Burnier
Krzysztof Narkiewicz
- NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021; 398(10304): 957–980.
- Muntner P, Miles MA, Jaeger BC, et al. Blood Pressure Control Among US Adults, 2009 to 2012 Through 2017 to 2020. Hypertension. 2022; 79(9): 1971–1980.
- Zdrojewski T, Rutkowski M, Bandosz P, Gaciong Z, Solnica B, Drygas W. Ocena rozowszechnienia i kontroli czynników ryzyka chorób serca i naczyń w Polsce — badania NATPOL 1997, 2002, 2011. In: Kopeć G, Pająk A. ed. Epidemiol i prewencja chorób układu krążenia. 1st ed. Medycyna Praktyczna, Kraków 2015: 57–64.
- Bress AP, Cohen JB, Anstey DE, et al. Inequities in Hypertension Control in the United States Exposed and Exacerbated by COVID-19 and the Role of Home Blood Pressure and Virtual Health Care During and After the COVID-19 Pandemic. J Am Heart Assoc. 2021; 10(11): e020997.
- Kreutz R, Dobrowolski P, Prejbisz A, et al. European Society of Hypertension COVID-19 Task Force Review. Lifestyle, psychological, socioeconomic and environmental factors and their impact on hypertension during the coronavirus disease 2019 pandemic. J Hypertens. 2021; 39(6): 1077–1089.
- Picone DS, Padwal R, Stergiou GS, et al. How to find and use validated blood pressure measuring devices. J Hum Hypertens. 2023; 37(2): 108–114.
- BP Monitors. https://stridebp.org/bp-monitors (17.07.2022).
- Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESHGuidelines for themanagement ofarterial hypertension. J Hypertens. 2018; 36(10): 1953–2041.
- Beaney T, Schutte AE, Stergiou GS, et al. MMM Investigators*. May Measurement Month 2019: The Global Blood Pressure Screening Campaign of the International Society of Hypertension. Hypertension. 2020; 76(2): 333–341.
- Figueiredo D, Azevedo A, Pereira M. Definition of hypertension: the impact of number of visits for blood pressure measurement. Rev Port Cardiol. 2009; 28(7–8): 775–783.
- Shah NP, Clare RM, Chiswell K, et al. Trends of blood pressure control in the U.S. during the COVID-19 pandemic. Am Heart J. 2022; 247: 15–23.
- Chamberlain AM, Cooper-DeHoff RM, Fontil V, et al. Disruption in Blood Pressure Control With the COVID-19 Pandemic: The PCORnet Blood Pressure Control Laboratory. Mayo Clin Proc. 2023; 98(5): 662–675.
- Feitosa FG, Feitosa ADM, Paiva AMG, et al. Impact of the COVID-19 pandemic on blood pressure control: a nationwide home blood pressure monitoring study. Hypertens Res. 2022; 45(2): 364–368.
- Pengo MF, Albini F, Guglielmi G, et al. Home blood pressure during COVID-19-related lockdown in patients with hypertension. Eur J Prev Cardiol. 2022; 29(3): e94–e96.
- Burnier M, Kjeldsen SE, Narkiewicz K, et al. Hypertension management during the COVID-19 pandemic: what can we learn for the future? Blood Press. 2022; 31(1): 47–49.
- Citoni B, Figliuzzi I, Presta V, et al. Home Blood Pressure and Telemedicine: A Modern Approach for Managing Hypertension During and After COVID-19 Pandemic. High Blood Press Cardiovasc Prev. 2022; 29(1): 1–14.
- Mancia G, Rea F, Ludergnani M, et al. Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19. N Engl J Med. 2020; 382(25): 2431–2440.
- Reynolds HR, Adhikari S, Iturrate E, et al. Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19. N Engl J Med. 2020; 382(25): 2441–2448.
- Laffin LJ, Kaufman HW, Chen Z, et al. Rise in Blood Pressure Observed Among US Adults During the COVID-19 Pandemic. Circulation. 2022; 145(3): 235–237.
- Wing RR, Venkatakrishnan K, Panza E, et al. Association of COVID-19 Stay-at-Home Orders With 1-Year Weight Changes. JAMA Netw Open. 2022; 5(6): e2217313.
- Corrigendum to: May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension. Eur Heart J. 2019; 40(37): 3109.
- Beaney T, Schutte AE, Tomaszewski M, et al. May Measurement Month 2017: an analysis of blood pressure screening results worldwide. Lancet Glob Healh. 2018; 6(7): e736–e743.
- Kallioinen N, Hill A, Horswill MS, et al. Sources of inaccuracy in the measurement of adult patients' resting blood pressure in clinical settings: a systematic review. J Hypertens. 2017; 35(3): 421–441.
- Fan WG, Wang WY, Meng YX, et al. Within-visit and between-visit intra-individual blood pressure variability in an unselected adult population from rural China. J Hypertens. 2021; 39(7): 1346–1351.
- Parati G, Stergiou GS, Dolan E, et al. Blood pressure variability: clinical relevance and application. J Clin Hypertens (Greenwich). 2018; 20(7): 1133–1137.
- Wang J, Shi X, Ma C, et al. Visit-to-visit blood pressure variability is a risk factor for all-cause mortality and cardiovascular disease: a systematic review and meta-analysis. J Hypertens. 2017; 35(1): 10–17.
- Stevens SL, Wood S, Koshiaris C, et al. Blood pressure variability and cardiovascular disease: systematic review and meta-analysis. BMJ. 2016; 354: i4098.
- Kollias A, Kyriakoulis KG, Stambolliu E, et al. Seasonal blood pressure variation assessed by different measurement methods: systematic review and meta-analysis. J Hypertens. 2020; 38(5): 791–798.
- Iwahori T, Miura K, Obayashi K, et al. Seasonal variation in home blood pressure: findings from nationwide web-based monitoring in Japan. BMJ Open. 2018; 8(1): e017351.
- Stergiou GS, Palatini P, Modesti PA, et al. Seasonal variation in blood pressure: Evidence, consensus and recommendations for clinical practice. Consensus statement by the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability. J Hypertens. 2020; 38(7): 1235–1243.
- Bombelli M, Toso E, Peronio M, et al. The Pamela study: main findings and perspectives. Curr Hypertens Rep. 2013; 15(3): 238–243.